0.85
price down icon10.83%   -0.1032
after-market Dopo l'orario di chiusura: .79 -0.06 -7.06%
loading
Precedente Chiudi:
$0.9532
Aprire:
$0.93
Volume 24 ore:
136.62K
Relative Volume:
0.22
Capitalizzazione di mercato:
$8.04M
Reddito:
$453.30K
Utile/perdita netta:
$-1.03M
Rapporto P/E:
-7.5088
EPS:
-0.1132
Flusso di cassa netto:
-
1 W Prestazione:
-12.19%
1M Prestazione:
+15.04%
6M Prestazione:
-87.86%
1 anno Prestazione:
-87.50%
Intervallo 1D:
Value
$0.8274
$0.9795
Intervallo di 1 settimana:
Value
$0.8274
$1.11
Portata 52W:
Value
$0.5301
$10.28

X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Company Profile

Name
Nome
X T L Biopharmaceuticals Ltd Adr
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
2
Name
Cinguettio
@xtlbio
Name
Prossima data di guadagno
2024-05-24
Name
Ultimi documenti SEC
Name
XTLB's Discussions on Twitter

Confronta XTLB con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
XTLB
X T L Biopharmaceuticals Ltd Adr
0.85 9.02M 453.30K -1.03M 0 -0.1132
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.17 120.98B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
771.25 80.15B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ARGX
Argen X Se Adr
864.42 51.56B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
354.75 47.74B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ONC
Beone Medicines Ltd Adr
336.16 37.38B 4.98B 69.59M 525.67M 0.5197

X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2015-05-08 Iniziato H.C. Wainwright Buy

X T L Biopharmaceuticals Ltd Adr Borsa (XTLB) Ultime notizie

pulisher
Jan 23, 2026

XTL Biopharmaceuticals Faces Subsidiary Insolvency Filing, Reviews $1.5 Million Loan Exposure - TipRanks

Jan 23, 2026
pulisher
Jan 23, 2026

XTL Biopharmaceuticals Flags Nasdaq Equity Deficiency, Given Deadline to Regain Compliance - TipRanks

Jan 23, 2026
pulisher
Jan 13, 2026

XTL Biopharmaceuticals Calls February 17 Extraordinary Meeting to Expand Share Capital and Approve NeuroNOS-Linked Financing - TipRanks

Jan 13, 2026
pulisher
Jan 13, 2026

Beyond Air Deals Autism-Focused NeuroNOS To XTL For Equity, Future Payments - Benzinga

Jan 13, 2026
pulisher
Jan 13, 2026

XTL Biopharmaceuticals Moves to Acquire NeuroNOS Stake from Beyond Air and Plans $2 Million Private Placement - TipRanks

Jan 13, 2026
pulisher
Dec 31, 2025

XTL Biopharmaceuticals Takes Major Impairment on The Social Proxy in First-Half 2025 Results - The Globe and Mail

Dec 31, 2025
pulisher
Dec 29, 2025

XTL Biopharmaceuticals Faces Nasdaq Bid-Price Deficiency, Given Until June 2026 to Regain Compliance - TipRanks

Dec 29, 2025
pulisher
Dec 23, 2025

12 Health Care Stocks Moving In Tuesday's After-Market Session - Sahm

Dec 23, 2025
pulisher
Dec 13, 2025

XTL Biopharmaceuticals Faces Leadership Changes at Social Proxy Subsidiary - The Globe and Mail

Dec 13, 2025
pulisher
Dec 06, 2025

XTL Biopharmaceuticals Announces CFO Transition Amid Strategic Appointments - The Globe and Mail

Dec 06, 2025
pulisher
Dec 02, 2025

Total debt per share of XTL Biopharmaceuticals Ltd. Sponsored ADR – LS:A2DK34 - TradingView

Dec 02, 2025
pulisher
Nov 23, 2025

Changes in working capital of XTL Biopharmaceuticals Ltd. Sponsored ADR – FWB:H2K2 - TradingView

Nov 23, 2025
pulisher
Nov 11, 2025

XTL Biopharmaceuticals Announces Board Changes Following Resignation - MSN

Nov 11, 2025
pulisher
Oct 08, 2025

Nothing is Better Than Stitch Fix Inc (SFIX) stock at the moment - Setenews

Oct 08, 2025
pulisher
Jul 28, 2025

XTL Biopharmaceuticals Approves Key Resolutions at Shareholder Meeting - TipRanks

Jul 28, 2025
pulisher
Jul 21, 2025

XTL Biopharmaceuticals Postpones Shareholders’ Meeting Due to Quorum Issue - TipRanks

Jul 21, 2025
pulisher
Mar 04, 2025

XTL Biopharmaceuticals Enters Sublicense Agreement with Biossil - TipRanks

Mar 04, 2025
pulisher
Dec 30, 2024

XTL Biopharmaceuticals Reports Financial Results Amid Regional Unrest - TipRanks

Dec 30, 2024
pulisher
Aug 14, 2024

XTL Biopharmaceuticals Expands with AI Company Acquisition - TipRanks

Aug 14, 2024
pulisher
Jul 22, 2024

XTL Biopharmaceuticals Confirms Board and Auditor Appointments - Investing.com

Jul 22, 2024
pulisher
Mar 25, 2024

symbol__ Stock Quote Price and Forecast - CNN

Mar 25, 2024
pulisher
Mar 21, 2024

U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.03% - Investing.com India

Mar 21, 2024
pulisher
Jan 05, 2023

Unusual VolumeStock ScreenerNews - Finviz

Jan 05, 2023
pulisher
Nov 20, 2021

XTLB Stock Price and Chart — NASDAQ:XTLB - TradingView

Nov 20, 2021
pulisher
Mar 20, 2021

XTL Biopharmaceuticals Ltd Share Price ADR Each Repr 100 Shs Spon - Hargreaves Lansdown

Mar 20, 2021
pulisher
Jan 17, 2021

XTLB Financial Statements & ChartsX.t.l. Biopharmaceuticals Ltd.Adr MacroTrends - CMLviz

Jan 17, 2021
pulisher
Jan 17, 2021

XTLB Pivot Points, Technical Analysis and Moving AveragesX.t.l. Biopharmaceuticals Ltd.Adr Technicals - CMLviz

Jan 17, 2021
pulisher
Mar 18, 2020

The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates - Yahoo Finance

Mar 18, 2020
pulisher
Mar 12, 2020

List of US Companies Releasing Earnings (EPS) Today - FXLeaders

Mar 12, 2020
pulisher
Nov 13, 2019

The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher - Benzinga

Nov 13, 2019
pulisher
Oct 10, 2019

XTLB Stock Price, Forecast & Analysis | XTL BIOPHARMACEUTICALS-ADR (NASDAQ:XTLB) - Chartmill

Oct 10, 2019
pulisher
Nov 03, 2017

XTLB Stock Price and Chart — TASE:XTLB - TradingView

Nov 03, 2017
pulisher
Sep 29, 2017

XTLB Stock Price | XTL Biopharmaceuticals Ltd. ADR Stock Quote (U.S.: Nasdaq) - MarketWatch

Sep 29, 2017
pulisher
Aug 14, 2017

Check out X T L Biopharmaceuticals Ltd's stock price (XTLB) in real time - CNBC

Aug 14, 2017
pulisher
Dec 14, 2016

XTLBX.T.L. Biopharmaceuticals Ltd. ADR Stock Price and Quote - Finviz

Dec 14, 2016
pulisher
Jun 07, 2016

INGN Stock Price | Inogen Inc. Stock Quote (U.S.: Nasdaq) - MarketWatch

Jun 07, 2016

X T L Biopharmaceuticals Ltd Adr Azioni (XTLB) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$99.82
price up icon 2.09%
$103.47
price up icon 0.87%
$34.40
price up icon 2.78%
$119.34
price up icon 1.14%
$162.64
price up icon 1.83%
biotechnology ONC
$336.16
price down icon 0.48%
Capitalizzazione:     |  Volume (24 ore):